First Manhattan’s VanEck Biotech ETF BBH Stock Holding History

First Manhattan’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-150	Closed	-$24.9K	–	721
2024 Q1	$24.9K	Hold	150	–	–	﹤0.01%	1000
2023 Q4	$24.8K	Hold	150	–	–	﹤0.01%	990
2023 Q3	$23.4K	Hold	150	–	–	﹤0.01%	1001
2023 Q2	$23.4K	Sell	150 -50	-25%	-$7.8K	﹤0.01%	1006
2023 Q1	$32.4K	Hold	200	–	–	﹤0.01%	1000
2022 Q4	$31.9K	Hold	200	–	–	﹤0.01%	1017
2022 Q3	$28K	Hold	200	–	–	﹤0.01%	1035
2022 Q2	$29K	Hold	200	–	–	﹤0.01%	1058
2022 Q1	$32K	Sell	200 -200	-50%	-$32K	﹤0.01%	1079
2021 Q4	$75K	Hold	400	–	–	﹤0.01%	916
2021 Q3	$80K	Hold	400	–	–	﹤0.01%	905
2021 Q2	$80K	Hold	400	–	–	﹤0.01%	892
2021 Q1	$70K	Hold	400	–	–	﹤0.01%	887
2020 Q4	$67K	Hold	400	–	–	﹤0.01%	854
2020 Q3	$64K	Hold	400	–	–	﹤0.01%	847
2020 Q2	$65K	Hold	400	–	–	﹤0.01%	829
2020 Q1	$51K	Buy	400 +200	+100%	+$25.5K	﹤0.01%	847
2019 Q4	$27K	Hold	200	–	–	﹤0.01%	989
2019 Q3	$23K	Sell	200 -2,150	-91%	-$247K	﹤0.01%	1029
2019 Q2	$303K	Buy	2,350 +200	+9%	+$25.8K	﹤0.01%	629
2019 Q1	$276K	Hold	2,150	–	–	﹤0.01%	650
2018 Q4	$238K	Hold	2,150	–	–	﹤0.01%	661
2018 Q3	$292K	Sell	2,150 -850	-28%	-$115K	﹤0.01%	661
2018 Q2	$359K	Hold	3,000	–	–	﹤0.01%	598
2018 Q1	$361K	Hold	3,000	–	–	﹤0.01%	583
2017 Q4	$373K	Hold	3,000	–	–	﹤0.01%	589
2017 Q3	$402K	Hold	3,000	–	–	﹤0.01%	565
2017 Q2	$376K	Hold	3,000	–	–	﹤0.01%	567
2017 Q1	$357K	Hold	3,000	–	–	﹤0.01%	578
2016 Q4	$322K	Hold	3,000	–	–	﹤0.01%	579
2016 Q3	$345K	Hold	3,000	–	–	﹤0.01%	568
2016 Q2	$307K	Hold	3,000	–	–	﹤0.01%	594
2016 Q1	$311K	Hold	3,000	–	–	﹤0.01%	583
2015 Q4	$380K	Hold	3,000	–	–	﹤0.01%	551
2015 Q3	$342K	Hold	3,000	–	–	﹤0.01%	572
2015 Q2	$404K	Hold	3,000	–	–	﹤0.01%	559
2015 Q1	$388K	Hold	3,000	–	–	﹤0.01%	562
2014 Q4	$346K	Hold	3,000	–	–	﹤0.01%	592
2014 Q3	$317K	Hold	3,000	–	–	﹤0.01%	604
2014 Q2	$286K	Hold	3,000	–	–	﹤0.01%	621
2014 Q1	$272K	Hold	3,000	–	–	﹤0.01%	628
2013 Q4	$265K	Hold	3,000	–	–	﹤0.01%	623
2013 Q3	$248K	Hold	3,000	–	–	﹤0.01%	627
2013 Q2	$233K	Buy	+3,000	New	+$233K	﹤0.01%	637